677 related articles for article (PubMed ID: 18313643)
21. D-Cycloserine enhances memory consolidation of hippocampus-dependent latent extinction.
Gabriele A; Packard MG
Learn Mem; 2007 Jul; 14(7):468-71. PubMed ID: 17600116
[TBL] [Abstract][Full Text] [Related]
22. The effects of intra-hippocampal microinfusion of D-cycloserine on fear extinction, and the expression of NMDA receptor subunit NR2B and neurogenesis in the hippocampus in rats.
Ren J; Li X; Zhang X; Li M; Wang Y; Ma Y
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():257-64. PubMed ID: 23523746
[TBL] [Abstract][Full Text] [Related]
23. [Extinction of emotional response as a novel approach of pharmacotherapy of anxiety disorders].
Lehner M; Wisłowska-Stanek A; Płaznik A
Psychiatr Pol; 2009; 43(6):639-53. PubMed ID: 20209877
[TBL] [Abstract][Full Text] [Related]
24. D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions.
Langton JM; Richardson R
Neuropsychopharmacology; 2008 Dec; 33(13):3096-102. PubMed ID: 18354389
[TBL] [Abstract][Full Text] [Related]
25. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
Lehner M; Wisłowska-Stanek A; Taracha E; Maciejak P; Szyndler J; Skórzewska A; Turzyńska D; Sobolewska A; Hamed A; Bidziński A; Płaźnik A
Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585
[TBL] [Abstract][Full Text] [Related]
26. Facilitation of conditioned fear extinction by d-cycloserine is mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala.
Yang YL; Lu KT
Neuroscience; 2005; 134(1):247-60. PubMed ID: 15951121
[TBL] [Abstract][Full Text] [Related]
27. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
[TBL] [Abstract][Full Text] [Related]
28. The effect of D-cycloserine on immediate vs. delayed extinction of learned fear.
Langton JM; Richardson R
Learn Mem; 2010 Nov; 17(11):547-51. PubMed ID: 20971937
[TBL] [Abstract][Full Text] [Related]
29. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
30. D-cycloserine into the BLA reverses the impairing effects of exposure to stress on the extinction of contextual fear, but not conditioned taste aversion.
Akirav I; Segev A; Motanis H; Maroun M
Learn Mem; 2009 Nov; 16(11):682-6. PubMed ID: 19861403
[TBL] [Abstract][Full Text] [Related]
31. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
32. D-cycloserine facilitates extinction of conditioned alcohol-seeking behaviour in rats.
Vengeliene V; Kiefer F; Spanagel R
Alcohol Alcohol; 2008; 43(6):626-9. PubMed ID: 18945754
[TBL] [Abstract][Full Text] [Related]
33. Absence of significant interactive effects of high-dose D-cycloserine and ethanol in healthy human subjects: preliminary insights into ethanol actions at the glycine B site of NMDA glutamate receptors.
Trevisan L; Petrakis IL; Pittman B; Gueorguieva R; D'Souza DC; Perry E; Limoncelli D; Krystal JH
Alcohol Clin Exp Res; 2008 Jan; 32(1):36-42. PubMed ID: 18028532
[TBL] [Abstract][Full Text] [Related]
34. Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation.
Saito Y; Matsumoto M; Yanagawa Y; Hiraide S; Inoue S; Kubo Y; Shimamura K; Togashi H
Synapse; 2013 Apr; 67(4):161-70. PubMed ID: 23152167
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacological support of exposure therapy in anxiety disorders. Animal experiment studies].
Koch M
Nervenarzt; 2002 May; 73(5):481-3. PubMed ID: 12078031
[TBL] [Abstract][Full Text] [Related]
36. Enhancing exposure-based therapy from a translational research perspective.
Hofmann SG
Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253
[TBL] [Abstract][Full Text] [Related]
37. The use of cognitive enhancers in animal models of fear extinction.
Kaplan GB; Moore KA
Pharmacol Biochem Behav; 2011 Aug; 99(2):217-28. PubMed ID: 21256147
[TBL] [Abstract][Full Text] [Related]
38. The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans.
Onur OA; Schlaepfer TE; Kukolja J; Bauer A; Jeung H; Patin A; Otte DM; Shah NJ; Maier W; Kendrick KM; Fink GR; Hurlemann R
Biol Psychiatry; 2010 Jun; 67(12):1205-11. PubMed ID: 20303474
[TBL] [Abstract][Full Text] [Related]
39. Effects of D-cycloserine on extinction and reinstatement of morphine-induced conditioned place preference.
Lu GY; Wu N; Zhang ZL; Ai J; Li J
Neurosci Lett; 2011 Oct; 503(3):196-9. PubMed ID: 21889577
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders.
McNally RJ
Clin Psychol Rev; 2007 Jul; 27(6):750-9. PubMed ID: 17292521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
